Back to Companies
EXOZYMES INC.
EXOZNasdaqCIK: 0002010788
Over the 10 most recent insider filings, EXOZYMES INC. (EXOZ) has seen activity from 5 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $6.4K bought versus $0 sold, a net purchase of $6.4K. Perriman Damien Alan (Chief Commercial Officer) is the most active by dollar volume, and the single largest transaction was $1.4M by Perriman Damien Alan. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.9M
Purchases
$6.4K
Sales
$0
Unique Insiders
5
Recent Insider Trades
10 loaded
| Sep 17 | EXOZ EXOZYMES INC. | Nawaz Fouad | Vice President- Finance | Award | $282.6K |
| Aug 25 | EXOZ EXOZYMES INC. | Korman Tyler Paz | Chief Scientific Officer | Exercise | $0 |
| Sep 2 | EXOZ EXOZYMES INC. | Heltzen Michael | Chief Executive Officer | Buy | $6.4K |
| Aug 25 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Exercise | $0 |
| Apr 8 | EXOZ EXOZYMES INC. | Nawaz Fouad | Vice President- Finance | Grant | $50.6K |
| Apr 8 | EXOZ EXOZYMES INC. | Opgenorth Paul Hideo | Vice President, Development | Grant | $33.8K |
| Apr 8 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Grant | $75.0K |
| Apr 8 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Other | $0 |
| Apr 8 | EXOZ EXOZYMES INC. | Perriman Damien Alan | Chief Commercial Officer | Grant | $1.4M |
| Apr 8 | EXOZ EXOZYMES INC. | Korman Tyler Paz | Chief Scientific Officer | Grant | $45.0K |
10 filings